Published in Trans Assoc Am Physicians on January 01, 1981
Modulation of adrenergic receptors and adrenergic functions in cold adapted humans. Eur J Appl Physiol (2007) 0.78
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Chloroplast transformation in Chlamydomonas with high velocity microprojectiles. Science (1988) 5.91
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Expression of the CD34 gene in vascular endothelial cells. Blood (1990) 4.41
Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med (1981) 3.98
Frailty in elderly people: an evolving concept. CMAJ (1994) 3.84
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest (1998) 3.66
Are Frozen Foods a Public Health Problem? Am J Public Health Nations Health (1947) 3.44
Attenuation of isoproterenol-mediated vasodilatation in blacks. N Engl J Med (1995) 3.25
Disclosure of authors' conflicts of interest: a follow-up. N Engl J Med (2000) 3.16
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13
A potent pressor response elicited by drinking water. Lancet (1999) 3.02
Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet (1999) 3.01
Racial differences in the response to drugs--pointers to genetic differences. N Engl J Med (2001) 2.90
A novel lymphotropic herpesvirus. Lancet (1987) 2.89
Molecular basis of ethnic differences in drug disposition and response. Annu Rev Pharmacol Toxicol (2001) 2.86
The neuropathic postural tachycardia syndrome. N Engl J Med (2000) 2.86
Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther (1979) 2.85
The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med (2001) 2.74
Geminiviruses: models for plant DNA replication, transcription, and cell cycle regulation. Crit Rev Biochem Mol Biol (2000) 2.72
Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med (2000) 2.53
Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med (1978) 2.50
Structural brain abnormalities associated with deletion at chromosome 22q11: quantitative neuroimaging study of adults with velo-cardio-facial syndrome. Br J Psychiatry (2001) 2.49
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Ultrastructural localization of bcl-2 protein. J Histochem Cytochem (1992) 2.48
The Dehydrogenation of Alcohols by Streptococci of Group B. J Bacteriol (1942) 2.46
Altered drug binding due to the use of indwelling heparinized cannulas (heparin lock) for sampling. Clin Pharmacol Ther (1979) 2.31
Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol (1999) 2.31
Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor. Pharmacol Rev (1983) 2.30
Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. N Engl J Med (1989) 2.29
No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol (2001) 2.28
A single bone marrow-derived stromal cell type supports the in vitro growth of early lymphoid and myeloid cells. Cell (1987) 2.27
Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. Pharm Res (1999) 2.24
Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops. Potential for oral-ophthalmic drug interaction. JAMA (1995) 2.18
Gene silencing from plant DNA carried by a Geminivirus. Plant J (1998) 2.10
Explicit and implicit neural mechanisms for processing of social information from facial expressions: a functional magnetic resonance imaging study. Hum Brain Mapp (2000) 2.04
Autonomic ganglionitis with severe hypertension, migraine, and episodic but fatal hypotension. Neurology (1996) 2.03
Analysis of 1071 gift procedures--the case for a flexible approach to treatment. Lancet (1988) 2.03
Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest (1981) 2.03
Murine B cell lymphopoiesis in long term culture. J Immunol Methods (1984) 1.98
Model system for plant cell biology: GFP imaging in living onion epidermal cells. Biotechniques (1999) 1.92
Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J (1998) 1.89
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation (1979) 1.88
Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab Dispos (2000) 1.87
Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosis. Cancer Res (2001) 1.86
The Southwestern Ontario Joint Replacement Pilot Project: electronic point-of-care data collection. Southwestern Ontario Study Group. Can J Surg (2001) 1.82
The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology (2007) 1.77
Regression forests for efficient anatomy detection and localization in computed tomography scans. Med Image Anal (2013) 1.76
Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol (1993) 1.76
Prazosin in normal subjects: plasma levels, blood pressure and heart rate. Br J Clin Pharmacol (1976) 1.75
Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation (1997) 1.73
Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res (1998) 1.71
Functional significance of dendritic swelling after loud sounds in the guinea pig cochlea. Hear Res (1983) 1.65
Cochlear action potential threshold and single unit thresholds. J Acoust Soc Am (1979) 1.65
Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control. Circulation (1998) 1.64
Determinants of anticoagulant control in patients receiving warfarin. Br J Clin Pharmacol (1977) 1.64
Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy. J Neuropathol Exp Neurol (2000) 1.63
Cardiovascular effects of prazosin in normotensive and genetically hypertensive rats. Clin Exp Pharmacol Physiol (1975) 1.63
Adenosine increases sympathetic nerve traffic in humans. Circulation (1991) 1.63
Effects of age and cigarette smoking on propranolol disposition. Clin Pharmacol Ther (1979) 1.62
Enhanced left ventricular contractility in autonomic failure: assessment using pressure-volume relations. J Am Coll Cardiol (1990) 1.60
Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry (1993) 1.60
Direct measurement of propranolol bioavailability during accumulation to steady-state. Br J Clin Pharmacol (1978) 1.60
Increased drug delivery to the brain by P-glycoprotein inhibition. Clin Pharmacol Ther (2000) 1.60
Postprandial alterations in cardiovascular hemodynamics in autonomic dysfunction states. Am J Cardiol (1981) 1.59
Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans. Mol Pharmacol (2001) 1.59
Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system. Am J Med (1997) 1.57
Oscillatory patterns in sympathetic neural discharge and cardiovascular variables during orthostatic stimulus. Circulation (2000) 1.55
Isolated failure of autonomic noradrenergic neurotransmission. Evidence for impaired beta-hydroxylation of dopamine. N Engl J Med (1986) 1.55
Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. BMJ (2011) 1.55
Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination. Clin Pharmacol Ther (1979) 1.55
Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med (1994) 1.54
Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J (1991) 1.54
Apoptosis in interleukin-3-dependent haemopoietic cells. Quantification by two flow cytometric methods. J Immunol Methods (1992) 1.53
Cardiovascular and respiratory effects of adenosine in conscious man. Evidence for chemoreceptor activation. Circ Res (1987) 1.52
A geminivirus induces expression of a host DNA synthesis protein in terminally differentiated plant cells. Plant Cell (1995) 1.52
The pressor response to water drinking in humans : a sympathetic reflex? Circulation (2000) 1.52
Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt. J Clin Invest (1997) 1.52
A geminivirus replication protein interacts with the retinoblastoma protein through a novel domain to determine symptoms and tissue specificity of infection in plants. EMBO J (2000) 1.51
Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry. Prostaglandins (1979) 1.48
Identification of the pharmacogenetic determinants of alfentanil metabolism: cytochrome P-450 3A4. An explanation of the variable elimination clearance. Anesthesiology (1992) 1.46
Interaction of carbon dioxide and sympathetic nervous system activity in the regulation of cerebral perfusion in humans. Hypertension (2000) 1.45
Hyperactivity in the auditory midbrain after acoustic trauma: dependence on cochlear activity. Neuroscience (2009) 1.43
Recordings from slices indicate that octopus cells of the cochlear nucleus detect coincident firing of auditory nerve fibers with temporal precision. J Neurosci (1995) 1.43
Increased toxicity and reduced clearance of lidocaine by cimetidine. Ann Intern Med (1982) 1.43
Propranolol withdrawal syndrome - why? Circulation (1978) 1.43
Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med (2005) 1.42
CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism. Clin Pharmacol Ther (2000) 1.42
Immunex takes premature step to guarantee Enbrel market share. Nat Biotechnol (2001) 1.39
Physician proposals could cost biotechs thousands. Nat Biotechnol (2000) 1.39
Dose-related effect of triazolam on postural sway. Clin Pharmacol Ther (1991) 1.39
Increased vascular adrenergic vasoconstriction and decreased vasodilation in blacks. Additive mechanisms leading to enhanced vascular reactivity. Hypertension (2000) 1.38
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther (1995) 1.38
Clinical correlates of sway in old age--sensory modalities. Age Ageing (1982) 1.38
Diversity of characteristic frequency rate-intensity functions in guinea pig auditory nerve fibres. Hear Res (1990) 1.38
Biological determinants of propranolol disposition in man. Clin Pharmacol Ther (1978) 1.35
Proliferating cell nuclear antigen transcription is repressed through an E2F consensus element and activated by geminivirus infection in mature leaves. Plant Cell (2001) 1.34
Short stature and chronic renal failure: what concerns children and parents? Arch Dis Child (1995) 1.34